Instituto Nacional de Saúde

Name

Instituto Nacional de Saúde

Legal name

Instituto Nacional de Saúde

Website

https://ins.gov.mz

Company type

Private

Founded year

1955

Operating status

Operating

Ownership category

akta.pro rank

Product category

Public Health Research and Reference Laboratory Services

NAICS

Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Data Integration, Interoperability & Reporting (ELR/HIE/CDC/NNDSS) (HLAJABAN)

akta.pro secondary industries

Health Data, Vital Statistics & Population Health Informatics (BPAIAJAM), Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight) (HLAJACAG), Clinical Trials Authorization & Oversight (GCP) (HLAJADAF)

Keywords

• Public health research
• Reference laboratory services
• Epidemiological surveillance
• Health workforce training
• Scientific publishing

Headquarters

HQ city

Marracuene

HQ country

Mozambique

HQ region

Africa

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Government Budget Allocation: INS receives direct government funding from the Mozambique Ministry of Health (MISAU) for core operations, salaries, and infrastructure maintenance. As a public technical-scientific institution, primary funding comes from the national treasury.
2. International Development Partner Funding: Research activities funded by international donors and development partners including WHO, Africa CDC, CDC Global Health, Global Fund, Clinton Health Access Initiative, European Union, Government of Canada, and various international research institutions.
3. Training and Course Fees: Revenue from postgraduate programs, short courses, Field Epidemiology Training Program (FETP), and professional training for health system personnel.
4. Laboratory Reference Services: Diagnostic laboratory services and quality control testing for the National Health Service and other institutions.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

INS is a state-owned national public health research institute that conducts and regulates health research, operates national reference laboratories (including ISO 15189-accredited molecular diagnostics, genomic surveillance, microbiology, immunology, parasitology, virology, and bacteriology), delivers training programs (Field Epidemiology Training Program, postgraduate, short courses), manages surveillance systems (COMSA, HDSS, IBBS), publishes peer-reviewed scientific journals (RMCS, Cadernos de Saúde Pública), and operates the REGISA national platform for registering human health research under Law 6/2023.

Product overview

Instituto Nacional de Saúde operates as a unified platform of public health research and institutional services rather than a modular software product. The core offering centers on REGISA, a mandatory digital platform for human health research registration and authorization in Mozambique. Supporting services include scientific publishing (Revista Moçambicana de Ciências de Saúde and Cadernos de Saúde Pública), health database catalog and data request services, public health reference laboratories, the National Health Library, training programs including the Field Epidemiology Training Program, and a quality management system accredited to ISO 15189. The institution also produces scientific reports, conducts health surveys, and provides genomic surveillance capabilities through its developing National Bioinformatics Center.

Differentiator

Problem solved

Functional benefit

Products and services

• REGISA — Plataforma Nacional de Registo de Investigação em Saúde Humana REGISA is the mandatory national digital platform for registration and authorization of human health research in Mozambique, enabling researcher registration, investigation documentation aligned with AGISA 2024-2028, digital certificate issuance with QR validation, and real-time implementation monitoring. It serves researchers, institutions, and the Ministry of Health under Law 6/2023.
• Cadernos de Saúde Pública (CSP) Cadernos de Saúde Pública is a quarterly open-access publication disseminating technical and scientific public health information, including surveillance data analyses, disease outbreak investigations, emergency response management, and evidence-based recommendations. It targets public health professionals, researchers, and policymakers in Mozambique.
• Revista Moçambicana de Ciências de Saúde (RMCS) RMCS is a peer-reviewed scientific journal publishing original research, reviews, and clinical case descriptions in health sciences, with particular focus on endemic and neglected diseases relevant to Portuguese-speaking countries. Published annually and targeted at researchers, clinicians, and academics.
• Laboratórios de Saúde Pública (Public Health Reference Laboratories) The Public Health Reference Laboratories at INS provide diagnostic support for epidemic outbreaks, quality control through reference laboratory systems, biosafety assurance, and laboratory services supporting INS research activities. They operate molecular diagnostics, genomic surveillance (SARS-CoV-2, tuberculosis, HIV), microbiology, immunology, bacteriology, virology, and parasitology with 300 samples/day capacity for high-risk pathogens including Ebola. Clients are the National Health Service and provincial health delegations.
• Cursos e Formação em Saúde (Training Programs) INS training programs include postgraduate courses, short-duration courses for health professionals, the Field Epidemiology Training Program (FETP) with 11 cohorts trained, internship opportunities, and Medical Residency in Public Health. The target audience is Mozambican health professionals, epidemiologists, laboratory technicians, and health researchers.
• Catalogue of Health Databases (Bases de Dados) The INS database catalog provides access to health survey data including HIV behavioral surveys (IBBS), sexual and reproductive health data, MozART HIV data, and other research datasets, with a data dictionary and data-request functionality. It targets external researchers, policymakers, and academic collaborators.
• Sistema de Gestão da Qualidade (Quality Management System) INS quality management infrastructure provides ISO 15189-accredited laboratory operations, quality policy documentation, quality manuals, and internal audit procedures for laboratory services. This is the framework underpinning the reference laboratory network and was recognized by IANPHI in 2024.
• Biblioteca Nacional de Saúde (BNS) — National Health Library The Biblioteca Nacional de Saúde provides bibliographic services, internet access, HINARI electronic resources, and support to health facilities through blue box libraries and Virtual Health Library (BVS) content. It serves health professionals, researchers, students, and institutions across Mozambique.
• Scientific and Technical Reports (Relatórios Científicos e Técnicos) Scientific and technical reports produced by INS include annual activity reports, triennial reports, specialized health surveys (HIV sero-epidemiological surveys, violence against children surveys, demographic surveillance), and genomic surveillance bulletins. Distributed to institutions, policymakers, and development partners.

Quantifiable outcome

• Maternal mortality reduced from 690 to 233 per 100,000 live births (1997 to 2022-2023)
• +5 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature7 records

Partnerships

22 partnerships are on record, tiered core and major.

• Ministry of Health (MISAU)coreStrategic or Co-development PartnerPrimary oversight relationship. INS is supervised by the Minister of Health who has authority to approve internal regulations, programs, activity plans, annual reports, create local representations, and supervise INS organs and documents.
• World Health Organization (WHO)coreStrategic or Co-development PartnerTechnical collaboration on global health policy, disease elimination programs, health emergencies, and capacity building. INS Director-General serves on WHO expert panels.
• Africa CDCcoreStrategic or Co-development PartnerRegional collaboration on disease surveillance, outbreak response, and public health capacity building. INS Director-General serves as Chair of Africa CDC Consultative Council.
• International Association of National Public Health Institutes (IANPHI)coreStrategic or Co-development PartnerGlobal network of national public health institutes. INS Director-General serves on the IANPHI Board of Directors, and INS received IANPHI recognition for ISO 15189 implementation.
• U.S. Centers for Disease Control and Prevention (CDC)coreStrategic or Co-development PartnerTechnical collaboration on disease surveillance, laboratory capacity building, Field Epidemiology Training Program, and public health research.
• Universidade Eduardo Mondlane (UEM)coreStrategic or Co-development PartnerPrimary academic partner for joint research programs, postgraduate training, and academic publications. Multiple collaborative research projects in health.
• Johns Hopkins University / Bloomberg School of Public HealthmajorStrategic or Co-development PartnerCollaborative research on health policy, maternal and child health, and international health programs. Technical support for health research capacity building.
• Médicos Sem Fronteiras (MSF)majorStrategic or Co-development PartnerCollaboration on disease surveillance, outbreak response, and health research in humanitarian contexts.
• Clinton Health Access InitiativemajorStrategic or Co-development PartnerSupport for diagnostic access, health system strengthening, and research on HIV, TB, and other diseases.
• Centro de Investigação em Saúde de Manhiça (CISM)coreStrategic or Co-development PartnerLeading Mozambican research institute collaborating on malaria, HIV, TB, and other disease research in Manhiça district.
• Karolinska InstitutemajorStrategic or Co-development PartnerAcademic collaboration on medical research, training, and capacity building. INS Deputy Director holds PhD from Karolinska.
• London School of Hygiene & Tropical Medicine (LSHTM)majorStrategic or Co-development PartnerResearch collaboration on tropical diseases, health systems, and epidemiology training.
• Fundação Oswaldo Cruz (Fiocruz)majorStrategic or Co-development PartnerBrazilian public health research institution collaborating on viral diseases, vaccine research, and health technology.
• ISGlobal BarcelonamajorStrategic or Co-development PartnerGlobal health research institute collaborating on malaria, child health, and health systems research.
• Elizabeth Glaser Pediatric AIDS Foundation (EGPAF)majorStrategic or Co-development PartnerCollaboration on HIV prevention and research, particularly related to pediatric HIV and prevention of mother-to-child transmission.
• Institute of Tropical Medicine Antwerp (ITM)majorStrategic or Co-development PartnerAcademic partnership on tropical disease research, diagnostics, and training.
• Instituto de Higiene e Medicina Tropical (IHMT) LisbonmajorStrategic or Co-development PartnerPortuguese academic institution collaborating on tropical medicine research and training.
• Imperial College LondonmajorStrategic or Co-development PartnerResearch collaboration on cardiovascular disease, chronic conditions, and advanced clinical research.
• National Institute of Meteorology (INAM)majorStrategic or Co-development PartnerCollaboration on climate change and health surveillance, environmental health monitoring, and climate adaptation planning.
• Earth Institute Columbia UniversitymajorStrategic or Co-development PartnerCollaboration on climate change and health impact assessment, environmental health research.
• SACIDSmajorStrategic or Co-development PartnerSouthern African Centre for Infectious Disease Surveillance - regional network for disease surveillance and outbreak response.
• HIV Vaccine Trials Network (HVTN)majorStrategic or Co-development PartnerInternational consortium conducting HIV vaccine trials. INS participates in multiple HIV vaccine clinical trials through this network.

Scale indicators8 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• National Institute for Communicable Diseases (NICD): South Africa's national public health institute providing reference laboratory, surveillance, and research services for communicable diseases. Most direct regional peer given shared mandate, African context, and similar scope (reference microbiology, genomic surveillance, outbreak response).
• Kenya Medical Research Institute (KEMRI): Kenya's national medical research institute with reference laboratory, clinical trials, and population health surveillance functions. Direct peer due to comparable African national research institute structure, HIV/TB/malaria research portfolio, and CDC partnership model.
• Ethiopian Public Health Institute (EPHI): Ethiopia's national public health institute with mandate for public health research, reference laboratory services, and surveillance. Direct peer given similar scope in Africa, focus on endemic disease surveillance, and FETP-style training programs.
• Fundação Oswaldo Cruz (Fiocruz): Brazilian public health research institution collaborating with INS on viral diseases, vaccine research, and health technology. Direct peer due to comparable Latin-style public health institute model, laboratory network, and Portuguese-language scientific publishing tradition.
• Noguchi Memorial Institute for Medical Research: Ghana's premier biomedical research institute at the University of Ghana. Comparable as an African national-level biomedical research entity with WHO reference laboratory status and genomic surveillance capabilities in tropical disease research.

Broad incumbents

• Africa CDC: Continental public health agency for the African Union coordinating disease surveillance and outbreak response across member states. INS Director-General chairs the Consultative Council, positioning INS as a key implementing partner for Africa CDC's regional mandate.
• U.S. Centers for Disease Control and Prevention (CDC): The largest national public health agency globally, partnering with INS on disease surveillance, laboratory capacity, and FETP programs. Broad incumbent peer given overlapping mandate and the technical assistance relationship INS has received historically.
• Robert Koch Institute (RKI): Germany's federal public health institute covering surveillance, research, and laboratory services. Comparable in institutional structure, ISO-quality laboratory operations, and European-style national public health institute model.
• Pasteur Institute: French-founded global network of biomedical research institutes with strong infectious disease surveillance and laboratory capabilities. Peer in terms of institutional model (national reference lab + research institute) and tropical disease focus.

Others

• International Association of National Public Health Institutes (IANPHI): Global network of national public health institutes. INS is an active member with the Director-General serving on the IANPHI Board. Relevant as an enabling/ecosystem organization rather than a direct peer, providing peer recognition, technical frameworks, and convening for institutes like INS.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/instituto_ins
• YouTubeyoutube.com/channel/UCRjN4oLhbiTX2nNon5Wmiow
• Facebookfacebook.com/ins.gov.mz

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto Nacional de Saúde